Pegvorhyaluronidase alfa Uses, Dosage, Side Effects and more
Pegvorhyaluronidase alfa is under investigation in clinical trial NCT02241187 (Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection).
| Attribute | Details |
|---|---|
| Trade Name | Pegvorhyaluronidase alfa |
| Generic | Pegvorhyaluronidase alfa |
| Pegvorhyaluronidase alfa Other Names | Pegvorhyaluronidase alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
